Publications by authors named "Rama Modali"

Claim this Profile
T
The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying otherwise therapy-refractory mutations.
Aditya Kulkarni, Joseph Ryan McDermott, Umesh Kathad, Rama Modali, Jean-Philippe Richard

Oncotarget· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications.
Umesh Kathad, Aditya Kulkarni, Joseph Ryan McDermott, Jordan Wegner, Peter Carr, Rama Modali

BMC Bioinformatics· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect modification by transferrin C2 polymorphism on lead exposure, hemoglobin levels, and IQ.
Ananya Roy, Adrienne S Ettinger, Howard Hu, David Bellinger, Joel Schwartz, Rama Modali

Neurotoxicology· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemoglobin, lead exposure, and intelligence quotient: effect modification by the DRD2 Taq IA polymorphism.
Ananya Roy, Howard Hu, David C Bellinger, Bhramar Mukherjee, Rama Modali

Environ Health Perspect· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological detection of viral large T antigen identifies a subset of Merkel cell carcinoma tumors with higher viral abundance and better clinical outcome.
Kishor Bhatia, James J Goedert, Rama Modali, Liliana Preiss, Leona W Ayers

Int J Cancer· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression.
Kishor Bhatia, James J Goedert, Rama Modali, Liliana Preiss, Leona W Ayers

Int J Cancer· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Merkel cell polyomavirus is not detected in mesotheliomas.
Kishor Bhatia, Rama Modali, James J Goedert

J Clin Virol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dopamine D2 receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial.
Gwen Murphy, Amanda J Cross, Leah S Sansbury, Andrew Bergen, Adeyinka O Laiyemo, Rama Modali

Int J Cancer· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial.
Gwen Murphy, Leah B Sansbury, Amanda J Cross, Rachael Stolzenberg-Solomon, Adeyinka Laiyemo, Rama Modali

Cancer Causes Control· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polynucleotide kinase 3' phosphatase variant, dietary variables and risk of adenoma recurrence in the Polyp Prevention Trial.
Gwen Murphy, Leah S Sansbury, Andrew W Bergen, Zhuoqiao Wang, Arthur Schatzkin, Rama Modali

Eur J Cancer Prev· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians.
Angie Stone, Luke D Ratnasinghe, Ginny L Emerson, Rama Modali, Terri Lehman

Cancer Epidemiol Biomarkers Prev· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia.
Thomas S Lin, Ian W Flinn, Rama Modali, Teresa A Lehman, Jennifer Webb

Blood· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer.
Luke D Ratnasinghe, Christian Abnet, You-Lin Qiao, Rama Modali, Rachael Stolzenberg-Solomon

Cancer Lett· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fc gamma RIIIa and Fc gamma RIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia.
Sherif S Farag, Ian W Flinn, Rama Modali, Teresa A Lehman, Donn Young

Blood· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening of mutations in the ras family of oncogenes by polymerase chain reaction-based ligase chain reaction.
Alfredo Martínez, Teresa A Lehman, Rama Modali, James L Mulshine

Methods Mol Med· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis